Last reviewed · How we verify
Pathological Gastric Hypersecretory Condition
Approved treatments
- Dexpure
Dexpure works by irreversibly inhibiting the H+/K+ ATPase enzyme in the stomach lining, reducing acid production. - Nexium · AstraZeneca
- Prilosec · AstraZeneca (originally Astra AB)
Irreversibly inhibits the hydrogen-potassium ATPase (proton pump) in gastric parietal cells, potently suppressing stomach acid secretion. - Aciphex · University of Utah
- Aciphex · Waylis
Aciphex works by irreversibly inhibiting the potassium-transporting ATPase enzyme in the stomach lining, reducing acid production. - Rabeprazol · Janssen-Cilag, S.A.
- Omeprazol · RenJi Hospital
Clinical guidelines
- FDA label — 1L
Omeprazole is used to manage pathological gastric hypersecretory conditions.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Pathological Gastric Hypersecretory Condition patent landscape — cliff calendar, originator estates, attackable patents
- Pathological Gastric Hypersecretory Condition treatment landscape brief
- Pathological Gastric Hypersecretory Condition treatment updates RSS
Frequently asked questions about Pathological Gastric Hypersecretory Condition
What drugs treat Pathological Gastric Hypersecretory Condition?
Tracked treatments include Dexpure, Nexium, Prilosec, Aciphex, Rabeprazol, Omeprazol.
What is the treatment for Pathological Gastric Hypersecretory Condition?
Standard treatment for Pathological Gastric Hypersecretory Condition includes Dexpure, Nexium, Prilosec, Aciphex, Rabeprazol. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Pathological Gastric Hypersecretory Condition?
FDA label publishes guidelines for Pathological Gastric Hypersecretory Condition. 1 guideline references tracked.
Related
- Treatment landscape: Pathological Gastric Hypersecretory Condition patent cliff · Pathological Gastric Hypersecretory Condition CI report
- Treatment: Dexpure
- Treatment: Nexium · AstraZeneca
- Treatment: Prilosec · AstraZeneca (originally Astra AB)
- Treatment: Aciphex · University of Utah
- Treatment: Aciphex · Waylis
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing